Methyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate

Catalog No.: 
ACEUBD954
CAS No.: 
91476-81-2
Molecular Formula: 
C8H11N3O2
Molecular Weight: 
181.20
Methyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate
IUPAC Namemethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate
MDL No.MFCD09909673
Molecular FormulaC8H11N3O2
Molecular Weight181.20
SMILESO=C(C1=CN2C(CNCC2)=N1)OC
InChI KeyAHIJWXPZLFMLRH-UHFFFAOYSA-N
Synonym91476-81-2 | methyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate | Imidazo[1,2-a]pyrazine-2-carboxylic acid, 5,6,7,8-tetrahydro-, methyl ester | 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylic acid methyl ester | METHYL 5H,6H,7H,8H-IMIDAZO[1,2-A]P
CAS No.91476-81-2
PubChem CID13247047

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACEUBD954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEUBD954 route product structure diagram
    ACEUBD95491476-81-2In Stock
Inquiry

2. ACEUBD954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEUBD954 route product structure diagram
    ACEUBD95491476-81-2In Stock
Inquiry

3. ACEUBD954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEUBD954 route product structure diagram
    ACEUBD95491476-81-2In Stock
Inquiry

Comments (0)